COLOMA JASON V (Chief Executive Officer) sold 5.9% of their position (1.94K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $50.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/18/2026ACC: 0001676170-26-000004
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-1.94K
Net shares
Net seller
$50.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.94K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−1.82K
Price / share
$26.00
Trade value
$47.37K
% of position
0.5%
5/15/2026
382.89K→381.07K
Common Stock
Indirect
Shares
−116.00
Price / share
$26.00
Trade value
$3.02K
% of position
0.4%
5/15/2026
31.12K→31K
Total
Net shares
−1.94K
Net value
-$50.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/15/2026 | S · Sale | −1.82K | $26.00 | $47.37K | 0.5% | 382.89K | 381.07K |
| Common Stock Indirect | 5/15/2026 | S · Sale | −116.00 | $26.00 | $3.02K | 0.4% | 31.12K | 31K |
| Total | −1.94K | -$50.39K | ||||||
Derivative Transactions0
No derivative transactions reported